Checkpoint Capital L.P.
- SEC CIK
- 0001977548
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 16
- −1 vs. Q1 2024
- Portfolio value
- $165.9M
- +$16.3M (+10.9%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RYTMRhythm Pharmaceuticals, Inc. | COM | 922,100 | $37.9M | 22.8% | +96,600+11.7% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 82,150 | $35.3M | 21.3% | +150+0.2% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 290,772 | $23.4M | 14.1% | +158,335+119.6% | Added | History |
| AVDLAvadel Pharmaceuticals PLC | Stock | 1,138,178 | $16.0M | 9.6% | +436,791+62.3% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 355,000 | $12.3M | 7.4% | +74,699+26.6% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 190,000 | $10.3M | 6.2% | 00.0% | Unchanged | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 875,000 | $9.01M | 5.4% | +429,839+96.6% | Added | History |
| CORTCorcept Therapeutics Inc | COM | 244,750 | $7.95M | 4.8% | −29,026−10.6% | Reduced | History |
| ATYRaTYR PHARMA INC | COM NEW | 1,946,477 | $3.04M | 1.8% | +500,000+34.6% | Added | History |
| PLRXPliant Therapeutics, Inc. | COM | 232,200 | $2.50M | 1.5% | +232,200 | New | History |
| KYMRKymera Therapeutics, Inc. | COM | 82,000 | $2.45M | 1.5% | +82,000 | New | History |
| CDTXCidara Therapeutics, Inc. | COM NEW | 145,417 | $1.74M | 1.0% | +145,417 | New | History |
| TRVITrevi Therapeutics, Inc. | COM | 500,089 | $1.49M | 0.9% | −5,993−1.2% | Reduced | History |
| APLTApplied Therapeutics, Inc. | COM | 227,470 | $1.06M | 0.6% | +7,470+3.4% | Added | History |
| SLNOSoleno Therapeutics Inc | COM | 19,695 | $803.6K | 0.5% | +19,695 | New | History |
| ALLKAllakos Inc. | COM | 649,957 | $650.0K | 0.4% | −118,007−15.4% | Reduced | History |
Sold out since Q1 2024 (5)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| MIRMMirum Pharmaceuticals, Inc. | COM | 362,193 | $9.10M | 6.1% | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 618,528 | $5.39M | 3.6% | History |
| VSTMVerastem, Inc. | COM NEW | 168,739 | $1.99M | 1.3% | History |
| GHRSGH Research PLC | ORDINARY SHARES | 185,653 | $1.98M | 1.3% | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 892,853 | $619.6K | 0.4% | History |